Pulse Biosciences Stock Performance
| PLSE Stock | USD 23.01 0.39 1.67% |
Pulse Biosciences holds a performance score of 11 on a scale of zero to a hundred. The company holds a Beta of 4.37, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Pulse Biosciences will likely underperform. Use Pulse Biosciences treynor ratio, kurtosis, period momentum indicator, as well as the relationship between the downside variance and day median price , to analyze future returns on Pulse Biosciences.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Pulse Biosciences are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, Pulse Biosciences exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (1.67) | Five Day Return 7.88 | Year To Date Return 71.84 | Ten Year Return 451.8 | All Time Return 451.8 |
1 | Acquisition by Zanganeh Mahkam of 30000 shares of Pulse Biosciences at 16.16 subject to Rule 16b-3 | 12/05/2025 |
2 | Pulse Biosciences Valuation Check After FDA IDE Approval for nPulse Cardiac Ablation Trial | 12/26/2025 |
3 | Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium | 01/06/2026 |
4 | New Cardiac Ablation Data and Board Appointment Might Change The Case For Investing In Pulse Biosciences | 01/12/2026 |
5 | Heres Why Were Not Too Worried About Pulse Biosciences Cash Burn Situation - | 01/15/2026 |
6 | Gap Down Is Pulse Biosciences Inc exposed to currency risks - July 2025 Weekly Recap High Conviction Trade Alerts - baoquankhu1.vn | 01/27/2026 |
7 | Pulse Biosciences nPulse Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium | 02/03/2026 |
8 | Acquisition by Sainz Maria of 3104 shares of Pulse Biosciences at 13.69 subject to Rule 16b-3 | 02/05/2026 |
9 | Pulse Biosciences Presents Late-Breaking Data from nPulse Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium | 02/06/2026 |
10 | A Look At Pulse Biosciences Valuation After Its Recent Share Price Surge | 02/09/2026 |
11 | Disposition of 20000 shares by Kevin Danahy of Pulse Biosciences at 23.52 subject to Rule 16b-3 | 02/10/2026 |
12 | Pulse Biosciences Is Up 70.4 percent After Strong First-in-Human nPulse AF Data Release Has The Bull Case Changed | 02/11/2026 |
| Begin Period Cash Flow | 44.4 M | |
| Total Cashflows From Investing Activities | -125 K |
Pulse Biosciences Relative Risk vs. Return Landscape
If you would invest 1,375 in Pulse Biosciences on November 17, 2025 and sell it today you would earn a total of 926.00 from holding Pulse Biosciences or generate 67.35% return on investment over 90 days. Pulse Biosciences is currently generating 1.0658% in daily expected returns and assumes 7.6154% risk (volatility on return distribution) over the 90 days horizon. In different words, 68% of stocks are less volatile than Pulse, and 79% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Pulse Biosciences Target Price Odds to finish over Current Price
The tendency of Pulse Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 23.01 | 90 days | 23.01 | near 1 |
Based on a normal probability distribution, the odds of Pulse Biosciences to move above the current price in 90 days from now is near 1 (This Pulse Biosciences probability density function shows the probability of Pulse Stock to fall within a particular range of prices over 90 days) .
Pulse Biosciences Price Density |
| Price |
Predictive Modules for Pulse Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pulse Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pulse Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pulse Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Pulse Biosciences is not an exception. The market had few large corrections towards the Pulse Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pulse Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pulse Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.57 | |
β | Beta against Dow Jones | 4.37 | |
σ | Overall volatility | 2.81 | |
Ir | Information ratio | 0.10 |
Pulse Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pulse Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pulse Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pulse Biosciences is way too risky over 90 days horizon | |
| Pulse Biosciences appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (53.59 M) with loss before overhead, payroll, taxes, and interest of (193 K). | |
| Pulse Biosciences currently holds about 14.8 M in cash with (36.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4. | |
| Pulse Biosciences has a poor financial position based on the latest SEC disclosures | |
| Roughly 74.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from simplywall.st: Pulse Biosciences Is Up 70.4 percent After Strong First-in-Human nPulse AF Data Release Has The Bull Case Changed |
Pulse Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pulse Stock often depends not only on the future outlook of the current and potential Pulse Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pulse Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 58.4 M | |
| Cash And Short Term Investments | 118 M |
Pulse Biosciences Fundamentals Growth
Pulse Stock prices reflect investors' perceptions of the future prospects and financial health of Pulse Biosciences, and Pulse Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pulse Stock performance.
| Return On Equity | -0.87 | ||||
| Return On Asset | -0.49 | ||||
| Operating Margin | (236.83) % | ||||
| Current Valuation | 1.47 B | ||||
| Shares Outstanding | 67.77 M | ||||
| Price To Earning | (22.54) X | ||||
| Price To Book | 16.82 X | ||||
| Price To Sales | 18,132 X | ||||
| Gross Profit | (193 K) | ||||
| EBITDA | (55.08 M) | ||||
| Net Income | (53.59 M) | ||||
| Cash And Equivalents | 14.8 M | ||||
| Cash Per Share | 0.40 X | ||||
| Total Debt | 8.9 M | ||||
| Debt To Equity | 0.45 % | ||||
| Current Ratio | 3.14 X | ||||
| Book Value Per Share | 1.37 X | ||||
| Cash Flow From Operations | (36.34 M) | ||||
| Earnings Per Share | (1.14) X | ||||
| Market Capitalization | 958.23 M | ||||
| Total Asset | 132.46 M | ||||
| Retained Earnings | (390.5 M) | ||||
| Working Capital | 109.39 M | ||||
| Current Asset | 4 M | ||||
| Current Liabilities | 660 K | ||||
About Pulse Biosciences Performance
By analyzing Pulse Biosciences' fundamental ratios, stakeholders can gain valuable insights into Pulse Biosciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Pulse Biosciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Pulse Biosciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 972.15 | 864.13 | |
| Return On Tangible Assets | (0.48) | (0.50) | |
| Return On Capital Employed | (0.53) | (0.55) | |
| Return On Assets | (0.47) | (0.49) | |
| Return On Equity | (0.42) | (0.40) |
Things to note about Pulse Biosciences performance evaluation
Checking the ongoing alerts about Pulse Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pulse Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pulse Biosciences is way too risky over 90 days horizon | |
| Pulse Biosciences appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (53.59 M) with loss before overhead, payroll, taxes, and interest of (193 K). | |
| Pulse Biosciences currently holds about 14.8 M in cash with (36.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4. | |
| Pulse Biosciences has a poor financial position based on the latest SEC disclosures | |
| Roughly 74.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from simplywall.st: Pulse Biosciences Is Up 70.4 percent After Strong First-in-Human nPulse AF Data Release Has The Bull Case Changed |
- Analyzing Pulse Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pulse Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Pulse Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pulse Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pulse Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pulse Biosciences' stock. These opinions can provide insight into Pulse Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Pulse Stock analysis
When running Pulse Biosciences' price analysis, check to measure Pulse Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulse Biosciences is operating at the current time. Most of Pulse Biosciences' value examination focuses on studying past and present price action to predict the probability of Pulse Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulse Biosciences' price. Additionally, you may evaluate how the addition of Pulse Biosciences to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stocks Directory Find actively traded stocks across global markets | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |